These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 12848965)
1. Autoantibodies to ion channels at the neuromuscular junction. Lang B; Vincent A Autoimmun Rev; 2003 Mar; 2(2):94-100. PubMed ID: 12848965 [TBL] [Abstract][Full Text] [Related]
2. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Vernino S; Lennon VA Muscle Nerve; 2002 Nov; 26(5):702-7. PubMed ID: 12402293 [TBL] [Abstract][Full Text] [Related]
3. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome]. Sakai W; Nakane S; Matsuo H Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992 [TBL] [Abstract][Full Text] [Related]
4. Immunology of disorders of neuromuscular transmission. Vincent A Acta Neurol Scand Suppl; 2006; 183():1-7. PubMed ID: 16637918 [TBL] [Abstract][Full Text] [Related]
5. Pathogenic autoantibodies to neuronal proteins in neurological disorders. Vincent A; Lily O; Palace J J Neuroimmunol; 1999 Dec; 100(1-2):169-80. PubMed ID: 10695727 [TBL] [Abstract][Full Text] [Related]
6. Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes. Cetin H; Vincent A Semin Neurol; 2018 Jun; 38(3):344-354. PubMed ID: 30011414 [TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption in patients with autoimmune ion channel disorders of the peripheral nervous system. Antozzi C Atheroscler Suppl; 2013 Jan; 14(1):219-22. PubMed ID: 23357168 [TBL] [Abstract][Full Text] [Related]
11. ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System. Vincent A Neuroscience; 2020 Jul; 439():48-61. PubMed ID: 32194225 [TBL] [Abstract][Full Text] [Related]
12. Autoantibodies, neurotoxins and the nervous system. Vincent A; Roberts M; Willison H; Lang B; Newsom-Davis J J Physiol Paris; 1995; 89(3):129-36. PubMed ID: 7581302 [TBL] [Abstract][Full Text] [Related]
13. [Autoimmune myasthenia and Lambert-Eaton myasthenic syndrome. Physiopathologic concepts]. Eymard B Ann Med Interne (Paris); 1989; 140(6):462-6. PubMed ID: 2696402 [TBL] [Abstract][Full Text] [Related]
14. Molecular targets for autoimmune and genetic disorders of neuromuscular transmission. Vincent A; Beeson D; Lang B Eur J Biochem; 2000 Dec; 267(23):6717-28. PubMed ID: 11082182 [TBL] [Abstract][Full Text] [Related]
15. [Immunopathogenesis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome]. Lisý L Bratisl Lek Listy; 1997 Apr; 98(4):217-20. PubMed ID: 9264830 [TBL] [Abstract][Full Text] [Related]
18. [Editorial introduction: from the structure and functions of the neuromuscular junction to the diseases]. Takamori M Brain Nerve; 2011 Jul; 63(7):635-40. PubMed ID: 21747132 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune disorders of the neuromuscular junction. Vincent A Neurol India; 2008; 56(3):305-13. PubMed ID: 18974557 [TBL] [Abstract][Full Text] [Related]
20. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome. Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]